Copeptin as a diagnostic PH marker in acute pulmonary embolism

Basit Öğe Kaydı
dc.authoridOzkan, Seda/0000-0003-1835-8820;
dc.authorwosidşen, ahmet/S-1096-2017
dc.authorwosidOzkan, Seda/AAE-8598-2019
dc.authorwosidBaykan, Necmi/AAR-7922-2021
dc.contributor.authorBaykan, Necmi
dc.contributor.authorYakar, Sule
dc.contributor.authorOzkan, Seda
dc.contributor.authorSen, Ahmet
dc.contributor.authorSalt, Omer
dc.contributor.authorDurukan, Polat
dc.date.accessioned2024-06-12T11:13:07Z
dc.date.available2024-06-12T11:13:07Z
dc.date.issued2022
dc.departmentTrakya Üniversitesien_US
dc.description.abstractObjective: The present study aimed to investigate the effectiveness of copeptin levels in detecting increased pulmonary artery pressure and right ventricular dysfunction in patients with acute pulmonary embolism. Methods: A total of 116 patients who presented to the emergency department with chest pain or dyspnea and were diagnosed with acute pulmonary embolism and 30 healthy controls were included in the study. Plasma copeptin levels of patients and healthy control group were measured. Right ventricular functions and pulmonary artery pressures were evaluated in echocardiography of patients diagnosed with acute pulmonary embolism. Results: Copeptin levels were significantly higher in patients with right ventricular dysfunction than in those without right ventricular dysfunction [median 1.06(0.03-7.14) vs. 0.59(0.31-2.50), p= 0.01]. Conclusion: Copeptin can be used as a new biomarker in the diagnosis of acute pulmonary embolism and in predicting right ventricular dysfunction and increased pulmonary artery pressure in patients with acute pulmonary embolism.en_US
dc.identifier.doi10.33808/clinexphealthsci.1054109
dc.identifier.endpage1045en_US
dc.identifier.issn2459-1459
dc.identifier.issue4en_US
dc.identifier.startpage1040en_US
dc.identifier.trdizinid1162674en_US
dc.identifier.urihttps://doi.org/10.33808/clinexphealthsci.1054109
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/1162674
dc.identifier.urihttps://hdl.handle.net/20.500.14551/23434
dc.identifier.volume12en_US
dc.identifier.wosWOS:000972204100033en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.publisherMarmara Univ, Inst Health Sciencesen_US
dc.relation.ispartofClinical And Experimental Health Sciencesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectPulmonary Embolismen_US
dc.subjectMortalityen_US
dc.subjectPulmonary Wedge Pressureen_US
dc.subjectRight Ventricular Dysfunctionen_US
dc.subjectVasopressinen_US
dc.subjectPrecursoren_US
dc.titleCopeptin as a diagnostic PH marker in acute pulmonary embolismen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu